CID 5329106

Toceranib

Structural Information

Molecular Formula
C22H25FN4O2
SMILES
CC1=C(NC(=C1C(=O)NCCN2CCCC2)C)/C=C\3/C4=C(C=CC(=C4)F)NC3=O
InChI
InChI=1S/C22H25FN4O2/c1-13-19(12-17-16-11-15(23)5-6-18(16)26-21(17)28)25-14(2)20(13)22(29)24-7-10-27-8-3-4-9-27/h5-6,11-12,25H,3-4,7-10H2,1-2H3,(H,24,29)(H,26,28)/b17-12-
InChIKey
SRSGVKWWVXWSJT-ATVHPVEESA-N
Compound name
5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide
Related CIDs

2D Structure

compound 2d structure
5
Annotation Hits

119
References

5053
Patents

396.19617 Da
Monoisotopic Mass

2.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 397.20345 196.7
[M+Na]+ 419.18539 202.8
[M-H]- 395.18889 200.8
[M+NH4]+ 414.22999 208.8
[M+K]+ 435.15933 195.3
[M+H-H2O]+ 379.19343 187.9
[M+HCOO]- 441.19437 210.7
[M+CH3COO]- 455.21002 204.3
[M+Na-2H]- 417.17084 188.7
[M]+ 396.19562 192.0
[M]- 396.19672 192.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe